Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
2.84 USD | -2.07% | -0.35% | -1.73% |
02-12 | Acasti Pharma Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023 | CI |
02-07 | Craig-Hallum Initiates Acasti Pharma With Buy Rating, $6 Price Target | MT |
Turnover - Change in analysts' estimates
Earnings Per Share (EPS) - Change in analysts' estimates
EBIT - Change in analysts' estimates
Turnover
Earnings Per Share (EPS)
EBIT
- Stock Market
- Equities
- ACST Stock
- Revisions Acasti Pharma Inc.